Dr. Fortner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
750 E Adams St
Syracuse, NY 13210Phone+1 315-464-6323Fax+1 315-464-6322
Education & Training
Duke University HospitalFellowship, Pediatric Pulmonology, 2006 - 2008- Duke University HospitalResidency, Pediatrics, 2004 - 2006
- Duke University HospitalResidency, Internal Medicine/Pediatrics, 2002 - 2004
University of Cincinnati College of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2012 - 2025
NC State Medical License 2002 - 2013- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 70 citationsROCK1 Phosphorylates and Activates Zipper-interacting Protein KinaseLaura Hagerty, Douglas H. Weitzel, Jenica Chambers, Christopher N. Fortner, Matthew H. Brush
The Journal of Biological Chemistry. 2007-02-16 - 54 citationsNormal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy.Christopher N Fortner, Julie M Seguin, Denise M. Kay
Journal of Cystic Fibrosis. 2021-04-09 - 33 citationsDrug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor.Bethany Collins, Christopher Fortner, Amanda Cotey, Charles R Jr Esther, Aaron Trimble
Journal of Cystic Fibrosis. 2022-07-01
Press Mentions
This Week: New Cystic Fibrosis Medication, and Seasonal Flu OutlookNovember 27th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
